IMNM News & Analysis

Immunome (IMNM) Chief Scientist Sells 9,438 Shares for $204,238

Jack Higgins, Chief Scientific Officer of Immunome (IMNM), sold 9,438 shares on April 2, 2026, for $204,238. Post-transaction, Higgins holds 22,000 direct shares and 3,000 indirect shares, having reduced his direct ownership by 30.02%. The share price at market close was $21.84, reflecting a one-year price change of 250%. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, indicating routine liquidity management rather than market speculation.